Our data showing that Dectin-1-deficiency does not entirely abrogate the NK-enhancing activity of CD11b+ or CD11c+ cells suggests the interesting possibility that other CLRs are also involved in the orchestration of innate immune cells for the efficient NK cell-mediated anti-tumor immune response. The gene discussed is ITGAX; the disease is neoplasm.